ScholarIQanswers from OpenAlex

Molecular and clinicopathological characteristics of <i>ROS1</i>‐rearranged non‐small‐cell lung cancers identified by next‐generation sequencing

PaperCitations, authors & open-access status

Molecular and clinicopathological characteristics of <i>ROS1</i>‐rearranged non‐small‐cell lung cancers identified by next‐generation sequencing is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Molecular and clinicopathological characteristics of <i>ROS1</i>‐rearranged non‐small‐cell lung cancers identified by next‐generation sequencing have?

ScholarIQcitation count

Molecular and clinicopathological characteristics of <i>ROS1</i>‐rearranged non‐small‐cell lung cancers identified by next‐generation sequencing has 47 citations in the OpenAlex counts ScholarIQ stores.

When was Molecular and clinicopathological characteristics of <i>ROS1</i>‐rearranged non‐small‐cell lung cancers identified by next‐generation sequencing published?

ScholarIQyear

Molecular and clinicopathological characteristics of <i>ROS1</i>‐rearranged non‐small‐cell lung cancers identified by next‐generation sequencing has 2020 year in the ScholarIQ index.

What is the open-access status of Molecular and clinicopathological characteristics of <i>ROS1</i>‐rearranged non‐small‐cell lung cancers identified by next‐generation sequencing?

ScholarIQoa status

Molecular and clinicopathological characteristics of <i>ROS1</i>‐rearranged non‐small‐cell lung cancers identified by next‐generation sequencing has gold oa status in the ScholarIQ index.

What is the DOI of Molecular and clinicopathological characteristics of <i>ROS1</i>‐rearranged non‐small‐cell lung cancers identified by next‐generation sequencing?

ScholarIQdoi

The DOI for Molecular and clinicopathological characteristics of <i>ROS1</i>‐rearranged non‐small‐cell lung cancers identified by next‐generation sequencing is on the source record.

What is the PMID of Molecular and clinicopathological characteristics of <i>ROS1</i>‐rearranged non‐small‐cell lung cancers identified by next‐generation sequencing?

ScholarIQpmid

The PMID for Molecular and clinicopathological characteristics of <i>ROS1</i>‐rearranged non‐small‐cell lung cancers identified by next‐generation sequencing is on the source record.

What is the OpenAlex record for Molecular and clinicopathological characteristics of <i>ROS1</i>‐rearranged non‐small‐cell lung cancers identified by next‐generation sequencing?

ScholarIQopenalex

The OpenAlex for Molecular and clinicopathological characteristics of <i>ROS1</i>‐rearranged non‐small‐cell lung cancers identified by next‐generation sequencing is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial